Cell transplants look promising for stroke recovery

August 26, 2002

St. Paul, MN - Using transplants of bone marrow cells improved the recovery from stroke in rat experiments, according to a study published in the August 27 issue of Neurology, the scientific journal of the American Academy of Neurology.

The rats treated with an intravenous transplant of adult human stromal cells (mature cells from bone marrow) had significant improvements in their ability to function 14 days after the stroke, compared to rats that did not receive transplants after a stroke.

"These are smart cells that selectively migrate to the site of injury and become little factories producing an array of helpful molecules to repair the tissue," said study author Michael Chopp, PhD, of Henry Ford Hospital in Detroit, Mich., and Oakland University in Rochester, Mich. "We believe this therapy shows promise in treating stroke, Parkinson's disease, spinal cord injury and traumatic brain injury."

For the study, bone marrow cells were taken from three healthy human donors. Strokes were then induced in the rats and they were given the cells intravenously one day after the stroke. Other groups treated with fibroblast cells or not treated served as controls.

The rats were tested on their motor and sensory abilities and on their reflexes before the stroke and at one day, seven days and 14 days after the stroke. In a test of sensory abilities 14 days after the stroke, the rats treated with marrow stromal cells completed the test 60 percent faster than the non-treated rats. A detailed neurological examination showed that 14 days after the stroke the treated rats had a 30-percent improvement in overall neurological score compared to the control rats.

Compared to the control rats, the rats receiving marrow stromal cells produced more neurotrophic factors and nerve growth factors that stimulate cells to grow. They also had less cell death in the area of the stroke than the control rats. Chopp said the next step is to test the procedure in small numbers of humans to make sure it is safe. Marrow stromal cells have been used in human cancer patients.

The treatment is exciting in part because it appears to give doctors a longer time window to treat stroke patients than current treatments, according to neurologist and stroke recovery researcher Thomas A. Kent, MD, of the University of Texas Medical Branch in Galveston, Texas, who wrote an editorial accompanying the article.

"It's very difficult to treat people with a stroke within a narrow time window," he said. "Many people still don't recognize the symptoms of stroke and get to an emergency room quickly enough for treatment. If this new treatment is effective, it could expand the treatment window by several hours or even longer."

Kent cautioned, however, that more studies are needed to determine the long-term effects of the transplants.
-end-
The study was supported by a grant from the National Institute of Neurological Disorders and Stroke.

The American Academy of Neurology, an association of more than 18,000 neurologists and neuroscience professionals, is dedicated to improving patient care through education and research. For more information about the American Academy of Neurology, visit its web site at www.aan.com.

For more information contact: Kathy Stone, 651-695-2763, kstone@aan.com
For a copy of the study contact: Cheryl Alementi at 651-695-2737, calementi@aan.com

American Academy of Neurology

Related Stroke Articles from Brightsurf:

Stroke alarm clock may streamline and accelerate time-sensitive acute stroke care
An interactive, digital alarm clock may speed emergency stroke care, starting at hospital arrival and through each step of the time-sensitive treatment process.

Stroke patients with COVID-19 have increased inflammation, stroke severity and death
Stroke patients who also have COVID-19 showed increased systemic inflammation, a more serious stroke severity and a much higher rate of death, compared to stroke patients who did not have COVID-19, according a retrospective, observational, cross-sectional study of 60 ischemic stroke patients admitted to UAB Hospital between late March and early May 2020.

'Time is vision' after a stroke
University of Rochester researchers studied stroke patients who experienced vision loss and found that the patients retained some visual abilities immediately after the stroke but these abilities diminished gradually and eventually disappeared permanently after approximately six months.

More stroke awareness, better eating habits may help reduce stroke risk for young adult African-Americans
Young African-Americans are experiencing higher rates of stroke because of health conditions such as high blood pressure, diabetes and obesity, yet their perception of their stroke risk is low.

How to help patients recover after a stroke
The existing approach to brain stimulation for rehabilitation after a stroke does not take into account the diversity of lesions and the individual characteristics of patients' brains.

Kids with headache after stroke might be at risk for another stroke
A new study has found a high incidence of headaches in pediatric stroke survivors and identified a possible association between post-stroke headache and stroke recurrence.

High stroke impact in low- and middle-income countries examined at 11th World Stroke Congress
Less wealthy countries struggle to meet greater need with far fewer resources.

Marijuana use might lead to higher risk of stroke, World Stroke Congress to be told
A five-year study of hospital statistics from the United States shows that the incidence of stroke has risen steadily among marijuana users even though the overall rate of stroke remained constant over the same period.

We need to talk about sexuality after stroke
Stroke survivors and their partners are not adequately supported to deal with changes to their relationships, self-identity, gender roles and intimacy following stroke, according to new research from the University of Sydney.

Standardized stroke protocol can ensure ELVO stroke patients are treated within 60 minutes
A new study shows that developing a standardized stroke protocol of having neurointerventional teams meet suspected emergent large vessel occlusion (ELVO) stroke patients upon their arrival at the hospital achieves a median door-to-recanalization time of less than 60 minutes.

Read More: Stroke News and Stroke Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.